Sol-Gel Technologies Ltd.

NASDAQ
SLGL
Stock
Yield per half year: +1 195.65%
Dividend yield: 0%
Sector: Healthcare

7.45 $

-0.013 $ -0.1742%
0.366 $
7.85 $

Min/max per year

Share chart Sol-Gel Technologies Ltd.

Extended chart Simple chart
Financial Markets by TradingView

About Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel.

more details
The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; SGT-610, a rare disease for the treatment of Gorlin Syndrome which has completed Phase II clinical trials; and Erlotinib and Tapinarof to treat other rare skin indications. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date
2018-01-23
ISIN
IL0011417206
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
link
All parameters

Grade

Underestimation
Title Value Grade
P/S 2.25 7
P/BV 0.8981 9
P/E 0 0
Efficiency
Title Value Grade
ROA -26.08 0
ROE -31.35 0
ROIC 0 0
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0 0
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA -0.1264 10
Debt/Ratio 0.0365 10
Debt/Equity 0.2425 10
Growth impulse
Title Value Grade
Yield Revenue, % 31.11 5
Yield Ebitda, % -65.74 0
Yield EPS, % -68.71 0
More

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 7.46 $ 0 $ 0 $ -0.17 % 0 % 0 %
Week 7.8 $ 0 $ 0 $ -4.49 % 0 % 0 %
Month 0.812 $ 7.45 $ 7.85 $ 817.49 % 0 % 0 %
Three month 0.555 $ 0.41 $ 7.85 $ 1242.34 % 0 % 0 %
Half a year 0.575 $ 0.41 $ 7.85 $ 1195.65 % 0 % 0 %
Year 0.805 $ 0.366 $ 7.85 $ 825.47 % 0 % 0 %
3 years 5.87 $ 0.366 $ 7.85 $ 26.92 % 0 % 0 %
5 years 8 $ 0.366 $ 15.49 $ -6.88 % 0 % 0 %
10 years 0 $ 0.366 $ 17.15 $ 0 % 0 % 0 %
Year to date 1.65 $ 0.41 $ 7.85 $ 351.52 % 0 % 0 %

Main owners

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Dr. Alon Seri-Levy Co-Founder, CEO & Director 411k 1961 (64 years)
Mr. Gilad Mamlok Advisor 367k 1968 (57 years)
Dr. Itzik Yosef Chief Operating Officer 236k 1976 (49 years)
Mr. Moshe Arkin Executive Chairman of the Board N/A 1953 (72 years)
Prof. David Avnir Co-Founder N/A
Ms. Tamar Fishman Jutkowitz VP & General Counsel N/A 1976 (49 years)
Dr. Karine Neimann VP of Projects & Planning and Chief Chemist N/A 1971 (54 years)
Mr. Eyal Ben-Or Chief Financial Officer

About company

Address: Israel, Ness Ziona, 7 Golda Meir Street - Open in google maps, Open in yandex maps
Website: https://www.sol-gel.com